Neumora Therapeutics, Inc. NMRA Q1 2025 earnings
Reported May 12, 2025 · After market close
EPS-$0.42Miss by $0.02
EPS estimate-$0.40
Next report
Aug 5, 2026 (In 1 week)EPS estimate-$0.23
Versus estimates
Diluted EPS
Ask the moment Neumora Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Neumora Therapeutics, Inc. report Q1 2025 earnings?
- Neumora Therapeutics, Inc. (NMRA) reported Q1 2025 earnings on May 12, 2025 after market close.
- What were Neumora Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Neumora Therapeutics, Inc. reported eps of $-0.42 for Q1 2025.
- Did Neumora Therapeutics, Inc. beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.40 by $0.02.
- How did Neumora Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 23.5% from $-0.34.
- Where can I find Neumora Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-069311) directly on SEC EDGAR. The filing index links above go to sec.gov.